20
Participants
Start Date
July 1, 2025
Primary Completion Date
December 1, 2026
Study Completion Date
January 1, 2027
Cannabidiol
Cannabidiol (CBD) is a non-psychoactive minor cannabinoid component of Cannabis sativa that is emerging as a treatment to mitigate pain, numbness, and tingling associated with peripheral neuropathy. CBD acts through multiple receptors to modulate central and peripheral neuropathic signaling pathways to alleviate pain.
University of Virginia
OTHER